Edmonds Duncan Registered Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Edmonds Duncan Registered Investment Advisors's GILD Position: Q3 2020 in Review
Edmonds Duncan Registered Investment Advisors sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,952 shares — an estimated $227K sold.
Edmonds Duncan Registered Investment Advisors first reported a position in GILD in Q4 2015 and held it in 19 quarters. The position peaked at $548K in Q4 2015. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- Edmonds Duncan Registered Investment Advisors reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
- Edmonds Duncan Registered Investment Advisors sold 2,952 Gilead Sciences shares in Q3 2020, an estimated $227K.
- Edmonds Duncan Registered Investment Advisors first reported a position in Gilead Sciences in Q4 2015 and held it in 19 quarters.
- Edmonds Duncan Registered Investment Advisors's Gilead Sciences position peaked at $548K in Q4 2015.
- 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on Edmonds Duncan Registered Investment Advisors's 13F filing for Q3 2020, filed 4 Nov 2020.